Clinical Trials Logo
  1. Home
  2. Hyperhomocysteinemia
  3. NCT06264570

Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels. — PERBIO-HC  

Hyperhomocysteinemia Clinical Trial

Official title:
Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels, Prospective,Double-blind Randomised Trial.

Clinical Trial Summary

The clinical trial assesses the effectiveness and safety of a genetically-determined personalized approach to prescribing bioactive substances in patients with elevated blood homocysteine levels. Hyperhomocysteinemia (HHcy) is a risk factor for cardiovascular diseases (CVD), potentially exacerbating the effects of arterial hypertension and high cholesterol levels, increasing the risks of heart disease, stroke, and venous thrombosis. The trial aims to reduce plasma homocysteine levels to normal values (<15 µmol/L) through a pilot, single-center, prospective, double-blind, placebo-controlled study. The study will involve a 6-month observation period with visits at 1, 3, and 6 months, assessing the efficacy of two composite bioactive substances not considered medicinal drugs. The primary endpoint is the reduction of homocysteine levels in patients with elevated levels, while secondary endpoints include lowering very low-density lipoprotein levels, absence of anxiety and depression (using the Spielberg Anxiety Scale), and the occurrence of major cardiovascular events. The sample size is planned for 111 patients across three groups, with a 1:1:2 distribution, considering a 40% reduction in homocysteine levels in the treated group and 5% in the control group, aiming for an 80% power and a 0.05 alpha. Inclusion criteria include adults aged 18-80 with elevated homocysteine (>15 µmol/L) and LDL cholesterol levels (≥1.4 mmol/L), without taking any substances that could influence homocysteine levels for at least one month prior. The trial will also conduct an interim analysis after enrolling 55 patients, using statistical analysis to evaluate the results.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06264570
Study type Interventional
Source S.LAB (SOLOWAYS)
Contact
Status Recruiting
Phase N/A
Start date October 23, 2023
Completion date November 30, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT00005482 - Homocyst(e)Ine, Vitamin Status, and CVD Risk N/A
Completed NCT02392767 - Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function N/A
Completed NCT02540642 - Effect of Vitamin B12 Supplementation on Glycaemic Control in Uncontrolled Hyperhomocysteinemic Type 2 Diabetic Patients N/A
Completed NCT01371357 - The Effects of 8-week Choline, Betaine, and Folic Acid Supplementation on Plasma Homocysteine Concentration During Guanidinoacetic Acid Loading in Young Healthy Volunteers Phase 3
Withdrawn NCT01871740 - CSPPT- Chronic Kidney Diseases Study Phase 4
Not yet recruiting NCT03720249 - Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults With Hyperhomocysteinemia N/A
Completed NCT06163443 - Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms. N/A
Completed NCT01391416 - Prevalence Of Hyperhomocysteinemia In Thai Chronic Kidney Disease (CKD) Patients N/A
Completed NCT00004495 - Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis N/A
Completed NCT00755664 - Effects of Low-dose Complex B-vitamins on Homocysteine and Framingham Risk Score Among Chinese Elderly Phase 3
Completed NCT02961972 - Effects of Oral Supplementation With Creatine on Systemic Microvascular Endothelial Function in Vegetarian Individuals N/A
Completed NCT02860338 - COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE N/A
Completed NCT00737126 - The Effect of Folic Acid Administration in the Progression of Microalbuminuria N/A
Completed NCT00626223 - 5-methyltetrahydrofolate Survival and Inflammation in ESRD Patients N/A
Completed NCT03631238 - The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions
Completed NCT03376490 - Study of the Association of Muscle Strength, Balance and Other Factors With Vitamin Levels Among Elderly Diabetics N/A
Enrolling by invitation NCT02817503 - Feasibility Study of the Intensive Systolic Blood Pressure Control Phase 4
Completed NCT01766310 - Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children Phase 4
Completed NCT00005483 - Plasma Homocysteine Distribution in the United States N/A
Completed NCT00473200 - Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine Phase 1